Dr. Steven Robert Brenner M.D.
Neurologist | Neurology
1438 S Grand Blvd St. Louis University Saint Louis MO, 63104About
Dr. Steven Brenner is a distinguished Neurologist in Saint Louis, MO. Dr. Brenner specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Brenner employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Brenner is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
University of Wales in Great Britain 1972
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN- Pain Medicine
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Vitamin E treatment affects the progression of mild cognitive impairment to dementia.
- A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
- A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.
- Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
- Searching for a relationship between manganese and welding and Parkinson's disease.
- An open study of botulinum-A toxin treatment of trigeminal neuralgia.
- Should the Babinski sign be part of the routine neurologic examination?
- Re: Altered arterial function in migraine of recent onset.
- Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
- Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
- Transmissible spongiform encephalopathy in the 21st Century: neuroscience for the clinical neurologist.
- Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.
- Reduced circulating angiogenic cells in Alzheimer disease.
- Hypothesis: intestinal barrier permeability may contribute to cognitive dysfunction and dementia.
- Re: Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.
Dr. Steven Robert Brenner M.D.'s Practice location
Dr. Steven Robert Brenner M.D.'s reviews
Write ReviewPatient Experience with Dr. Brenner
Recommended Articles
- What Is Valproic Acid?
Generic Name: Valproic AcidBrand Name: Valproate Sodium, Depacon, Depakene, StavzorIntroductionValproic acid is an anticonvulsant that works by restoring or increasing the level of certain chemicals in the brain. This medication can be used alone or in combination with other types of seizure...
- Wandering and Dementia
What is wandering?Wandering is an act of aimless movement mostly done by people who are suffering from some neurological problems such as dementia and autism, among others. These conditions affect most of the elderly and young children. Therefore, parents of young children who have autism, or sons...
- The Three Best Treatment Methods for Muscular Dystrophy
Muscular dystrophy is a very common condition that can happen to people of different ages. The thing about muscular dystrophy is that there is no definite cure for it. However, there are ways to manage the condition. There are a lot of medications and therapies that can be used in order to keep it...
- Coping with Muscular Dystrophy
Discussing with a child that they have a muscle wasting disease is not easy. People who are diagnosed with muscular dystrophy have a mind that functions normally, but a body that does not. Being a parent of a child with MD revolves around acceptance. When you get past the initial fear and...
- Recently Approved Multiple Sclerosis Drug Shows Promise
Only 50 years ago, there was no way possible to treat multiple sclerosis. Then, in the mid-1970s, a team of researchers and doctors used chemotherapy for the first time to treat the neurological disease. Since that first treatment, more than 10 new drugs have been developed and approved. Some of...
- Lemtrada Gains FDA Approval to Treat Multiple Sclerosis
In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...
Nearby Providers
- Dr. Srikanth Damodaram M.D.1438 S Grand Blvd Saint Louis MO 63104
- Alireza Shams M.D.1402 S Grand Blvd Saint Louis MO 63104
- Dr. Jafar Kafaie M.D., PH.D.1225 S GRAND BLVD SAINT LOUIS MO 63104
- Dr. Glen Alan Fenton MD1465 S GRAND BLVD SAINT LOUIS MO 63104
- Dr. Shulamit Menashe Portnoy MD1465 S GRAND BLVD ST. LOUIS MO 63104
- Dr. Bingzhong Chen M.D.1438 S Grand Blvd Saint Louis MO 63104